Stephen R. Davis

Stephen Davis has over 20 years of senior management experience in the pharmaceutical industry and currently serves as President and Chief Executive Officer of ACADIA Pharmaceuticals, a biotechnology company focused on developing drug candidates for neurological and central nervous system disorders. Prior to joining ACADIA, Mr Davis held Executive Vice President and COO roles at Heron Therapeutics and Ardea Biosciences, Inc., where he led core business and finance functions and was instrumental in strategic growth initiatives. Previously, he served in successive senior executive positions including CFO, COO, and CEO at Neurogen Corporation, where he completed multiple collaborations and product acquisitions with global pharmaceutical companies. Mr Davis received his BS in Accounting from Southern Nazarene University and completed his JD at Vanderbilt University Law School. He recently served on the Boards of Directors at Synageva BioPharma Corporation prior to its acquisition by Alexion Pharmaceuticals and at Furiex Pharmaceuticals prior to its acquisition by Forest.